Table 1.
The age, sex distributions, and IL-30 level in the psoriatic and control groups.
| Psoriasis | Control | Total | |||||
|---|---|---|---|---|---|---|---|
| No. | (%) | No. | (%) | No. | (%) | p | |
| Age (years) | |||||||
| <40 | 10 | (38.5) | 13 | (50.0) | 23 | (44.2) | |
| 40–49 | 6 | (23.1) | 4 | (15.4) | 10 | (19.2) | |
| ≥50 | 10 | (38.5) | 9 | (34.6) | 19 | (36.5) | 0.656# |
| Mean (±SD) | 45.5 | (±12.8) | 40.1 | (±16.2) | 0.188† | ||
| Sex | |||||||
| Male | 18 | (69.2) | 12 | (46.2) | 30 | (57.7) | |
| Female | 8 | (30.8) | 14 | (53.8) | 22 | (42.3) | 0.092# |
| Total | 26 | (100.0) | 26 | (100.0) | 52 | (100.0) | |
| IL-30 | |||||||
| Mean (±SD) | 111.96 | (±149.66) | 33.76 | (±56.48) | <0.001‡ | ||
IL-30, interleukin-30; SD, standard deviation. †By t-test for two independent samples. #By chi-square test. ‡By Mann–Whitney test.